Silence Therapeutics plc Stock
Stocks
SLN
US82686Q1013
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.545 USD | +2.74% |
|
-6.11% | +56.74% |
| Market Cap | 328M 439M 384M 355M 618M 42.21B 629M 4.23B 1.66B 20.67B 1.65B 1.61B 71.17B | P/E 2026 * |
-15.5x | P/E 2027 * | -13.8x |
|---|---|---|---|---|---|
| Enterprise Value | 182M 243M 213M 197M 342M 23.36B 348M 2.34B 919M 11.44B 914M 893M 39.39B | EV / Sales 2026 * |
72.8x | EV / Sales 2027 * | 22.8x |
| Free-Float |
69.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Silence Therapeutics plc
| 1 day | +2.37% | ||
| 1 week | -6.11% | ||
| Current month | -13.21% | ||
| 1 month | +36.14% | ||
| 3 months | +55.72% | ||
| 6 months | +62.35% | ||
| Current year | +56.74% |
| 1 week | 8.91 |  | 10.42 |
| 1 month | 6.52 | | 11.06 |
| Current year | 4.19 | | 11.06 |
| 1 year | 4.19 | | 11.06 |
| 3 years | 1.97 | | 27.72 |
| 5 years | 1.97 | | 27.72 |
| 10 years | 1.97 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Ross
CEO | Chief Executive Officer | 72 | 01/12/2025 |
Rhonda Hellums
DFI | Director of Finance/CFO | 54 | 01/02/2022 |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
David Lemus
BRD | Director/Board Member | 63 | 21/06/2018 |
Iain Ross
CHM | Chairman | 72 | 01/01/2004 |
Tim McInerney
BRD | Director/Board Member | 65 | 05/05/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07-06 | Sell | 865,112 | 0.6105% | |||
| 01-02 | Free | Director | 90,000 | 0.0635% | ||
| 01-02 | Free | Chief Technology Officer | 300,000 | 0.2117% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.74% | -6.11% | +51.75% | +64.31% | 439M | |
| -1.05% | +1.39% | +3.15% | +6.98% | 50.61B | |
| +0.48% | -2.93% | +381.81% | +593.44% | 39.11B | |
| +0.40% | -0.03% | +30.00% | -5.85% | 34.64B | |
| +0.85% | -0.82% | +21.53% | +56.08% | 33.79B | |
| -1.31% | -1.76% | +1.59% | +27.01% | 26.89B | |
| +0.62% | -0.28% | - | - | 16.47B | |
| +1.62% | -1.68% | +67.66% | +120.85% | 15.14B | |
| -0.72% | +0.12% | +14.69% | +16.95% | 13.85B | |
| +1.54% | -0.13% | +12.69% | -31.57% | 12.72B | |
| Average | +0.47% | -2.61% | +64.99% | +94.24% | 24.37B | |
| Weighted average by Cap. | +0.07% | -1.16% | +80.61% | +121.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.5M 3.34M 2.92M 2.7M 4.7M 321M 4.78M 32.21M 12.64M 157M 12.56M 12.28M 541M | 3.44M 4.61M 4.03M 3.72M 6.48M 443M 6.6M 44.41M 17.43M 217M 17.32M 16.93M 747M |
| Net income | -50.34M -67.45M -58.94M -54.49M -94.8M -6.48B -96.52M -650M -255M -3.17B -253M -248M -10.92B | -84.67M -113M -99.13M -91.64M -159M -10.9B -162M -1.09B -429M -5.34B -426M -417M -18.37B |
| Net Debt | -146M -196M -171M -159M -276M -18.85B -281M -1.89B -742M -9.23B -737M -721M -31.78B | -249M -334M -292M -270M -470M -32.1B -478M -3.22B -1.26B -15.72B -1.26B -1.23B -54.12B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/07/26 | $9.470 | +1.94% | 241,734 |
| 13/07/26 | $9.290 | +2.20% | 233,638 |
| 10/07/26 | $9.090 | -7.81% | 365,407 |
| 09/07/26 | $9.860 | -0.90% | 232,796 |
| 08/07/26 | $9.950 | -1.97% | 494,240 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
